These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome. Hasumi H, Baba M, Hasumi Y, Furuya M, Yao M. Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100 [Abstract] [Full Text] [Related]
4. Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn. Hasumi H, Baba M, Hasumi Y, Lang M, Huang Y, Oh HF, Matsuo M, Merino MJ, Yao M, Ito Y, Furuya M, Iribe Y, Kodama T, Southon E, Tessarollo L, Nagashima K, Haines DC, Linehan WM, Schmidt LS. Proc Natl Acad Sci U S A; 2015 Mar 31; 112(13):E1624-31. PubMed ID: 25775561 [Abstract] [Full Text] [Related]
5. Folliculin variants linked to Birt-Hogg-Dubé syndrome are targeted for proteasomal degradation. Clausen L, Stein A, Grønbæk-Thygesen M, Nygaard L, Søltoft CL, Nielsen SV, Lisby M, Ravid T, Lindorff-Larsen K, Hartmann-Petersen R. PLoS Genet; 2020 Nov 31; 16(11):e1009187. PubMed ID: 33137092 [Abstract] [Full Text] [Related]
6. Identification and characterization of a novel folliculin-interacting protein FNIP2. Hasumi H, Baba M, Hong SB, Hasumi Y, Huang Y, Yao M, Valera VA, Linehan WM, Schmidt LS. Gene; 2008 May 31; 415(1-2):60-7. PubMed ID: 18403135 [Abstract] [Full Text] [Related]
8. Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling. Baba M, Hong SB, Sharma N, Warren MB, Nickerson ML, Iwamatsu A, Esposito D, Gillette WK, Hopkins RF, Hartley JL, Furihata M, Oishi S, Zhen W, Burke TR, Linehan WM, Schmidt LS, Zbar B. Proc Natl Acad Sci U S A; 2006 Oct 17; 103(42):15552-7. PubMed ID: 17028174 [Abstract] [Full Text] [Related]
16. Birt-Hogg-Dube syndrome: clinicopathological features of the lung. Furuya M, Nakatani Y. J Clin Pathol; 2013 Mar 01; 66(3):178-86. PubMed ID: 23223565 [Abstract] [Full Text] [Related]
18. FLCN: The causative gene for Birt-Hogg-Dubé syndrome. Schmidt LS, Linehan WM. Gene; 2018 Jan 15; 640():28-42. PubMed ID: 28970150 [Abstract] [Full Text] [Related]
19. Characterization of a splice-site mutation in the tumor suppressor gene FLCN associated with renal cancer. Bartram MP, Mishra T, Reintjes N, Fabretti F, Gharbi H, Adam AC, Göbel H, Franke M, Schermer B, Haneder S, Benzing T, Beck BB, Müller RU. BMC Med Genet; 2017 May 12; 18(1):53. PubMed ID: 28499369 [Abstract] [Full Text] [Related]
20. Disruption of tubular Flcn expression as a mouse model for renal tumor induction. Chen J, Huang D, Rubera I, Futami K, Wang P, Zickert P, Khoo SK, Dykema K, Zhao P, Petillo D, Cao B, Zhang Z, Si S, Schoen SR, Yang XJ, Zhou M, Xiao GQ, Wu G, Nordenskjöld M, Tauc M, Williams BO, Furge KA, Teh BT. Kidney Int; 2015 Nov 12; 88(5):1057-69. PubMed ID: 26083655 [Abstract] [Full Text] [Related] Page: [Next] [New Search]